Latest news
De Clercq & Partners Wins Opposition Procedure Firm of the Year at LMG Life Sciences EMEA Awards!
Read more | De Clercq & Partners Wins Opposition Procedure Firm of the Year at LMG Life Sciences EMEA Awards!Cloudy with a chance of patents: Vaping device prompts Enlarged Board of Appeal referral on using description to interpret claims
Read more | Cloudy with a chance of patents: Vaping device prompts Enlarged Board of Appeal referral on using description to interpret claimsCongratulations to Verónica Rojas De La Parra: Graduate of Fondazione Politecnico di Milano's European Patent Litigator Program!
Read more | Congratulations to Verónica Rojas De La Parra: Graduate of Fondazione Politecnico di Milano's European Patent Litigator Program!- General
De Clercq & Partners awarded as Benelux Patent Firm of the Year by MIP!
Read more | De Clercq & Partners awarded as Benelux Patent Firm of the Year by MIP!Flying high: 2023's record patent applications signal innovation boom
Read more | Flying high: 2023's record patent applications signal innovation boomCongratulations to Robrecht Dumarey, Jeff Gyi, and Delphine Debruyn: Graduates of Fondazione Politecnico di Milano's European Patent Litigator Program!
Read more | Congratulations to Robrecht Dumarey, Jeff Gyi, and Delphine Debruyn: Graduates of Fondazione Politecnico di Milano's European Patent Litigator Program!EPO clarifies implementation of new European Qualifying Exam
Read more | EPO clarifies implementation of new European Qualifying ExamChanges in Requirements for Recording Transfers and Licensing Transactions of European Patent Applications
Read more | Changes in Requirements for Recording Transfers and Licensing Transactions of European Patent ApplicationsGuidelines amended to clarify the practice relating to the novelty assessment of selection inventions
Read more | Guidelines amended to clarify the practice relating to the novelty assessment of selection inventionsEPO rules that Broad Institute’s CRISPR patent priority is valid
Read more | EPO rules that Broad Institute’s CRISPR patent priority is validUNITARY PATENTS – A NUMERICAL JOURNEY IN THE EUROPEAN PATENT LANDSCAPE
Read more | UNITARY PATENTS – A NUMERICAL JOURNEY IN THE EUROPEAN PATENT LANDSCAPEEpi position paper on ban on patents on NGT plants
Read more | Epi position paper on ban on patents on NGT plantsA sneak preview on the new EPO Guidelines for Examination 2024
Read more | A sneak preview on the new EPO Guidelines for Examination 2024